Hyperfine Inc (HYPR) Stock Price, Quote & News

Company Profile

Hyperfine, Inc., a health technology company, engages in the production, supply, service, and commercialization of magnetic resonance imaging (MRI) products. Its Swoop Portable MR Imaging System produces images at a lower magnetic field strength than conventional MRI scanners. The company also offers support and technical assistance services, as well as Hyperfine Image Viewer, a cloud picture archiving and communication system. It serves intensive care units, neurology offices, emergency departm...

Industry: Medical Devices

Sector: Healthcare

Phone: 866 796 6767

Website: www.hyperfinemri.com

Address:

351 New Whitfield Street, Guilford, United States

Mickf2022 Aug. 12 at 9:42 PM

$HYPR This will go down to 0.70 or a shade under before consolidation. Its going to need some real good news before year end or a cash crisis could T-Bone the stock.. i have owned it and not lost much on it but got out before earnings release. I just feel they are in a bind with limited scope atm and they will need cash .

0 · Reply

Dynel Aug. 12 at 4:26 PM

$HYPR

0 · Reply

Cold_in_the_North Aug. 12 at 3:17 PM

$HYPR this would be a good place for insiders to make some buys, and show their confidence.

0 · Reply

Stockwhisperr Aug. 10 at 3:30 PM

$BFLY Buckle up a voilent move is coming and it will leave many speechless and others in disbelief. BFLY has a huge pipeline despite the negative narrative from short sellers which are few and far between. If you follow smart money you will see only a handful of institutions are short. - Home healthcare commercial contract begins in Q4. - Pending FDA approval for 4th Gen chip - Apollo is in development and will likely be released to market in 2028 which is what MidJourney needs for their whole body scanners. - Workstations will be released in 2028 for hospitals seeking enterprise solutions - New partnerships for Butterfly Embedded, Butterfly Garden, Compass AI. - New revenue stream from entering the Brazil market - Software revenues will continue to grow. - BFLY transforming from a medical device to a semiconductor company. These are just a few in the pipeline. What’s coming will be epic in 2027! Few Understand 🦋 $ARKG $HYPR $AAPL $AAOI

2 · Reply

Number_4 Aug. 7 at 10:50 AM

$HYPR Always more of the same here. Mgmt CANNOT get sales traction, this name burns cash and now is fully using the ATM to dilute us longs!!!! Easier short ever if it gets back to $1.25.

0 · Reply

EarningsInsider Aug. 6 at 9:22 PM

https://www.marketbeat.com/earnings/reports/2026-8-6-hyperfine-inc-stock/ $HYPR Hyperfine Earnings Transcript

0 · Reply

Tl5000 Aug. 6 at 9:03 PM

$HYPR such a small market cap…cmon HYPR! Light at end of tunnel to get movin!!

0 · Reply

Cold_in_the_North Aug. 6 at 8:36 PM

$HYPR 4th consecutive quarter with gross profit margin over 50%

0 · Reply

StocktwitsEarnings Aug. 6 at 8:15 PM

$HYPR Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.09 up 25.00% YoY • Reported revenue of $3.9M up 44.81% YoY

0 · Reply

Cold_in_the_North Aug. 6 at 8:11 PM

$HYPR https://investors.hyperfine.io/news-releases/news-release-details/hyperfine-inc-reports-second-quarter-2026-financial-results/

0 · Reply

Hyperfine price target lowered to $1.60 from $2 at B. Riley

2026-08-06T20:31:06.000Z - 12 days ago

Hyperfine reports Q2 EPS (9c), consensus (9c)

2026-08-06T20:30:39.000Z - 12 days ago

Hyperfine sees FY26 revenue $20M-$22M, consensus $20.16M

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Hyperfine Earnings Call Transcript: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Hyperfine Earnings release: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Hyperfine Quarterly report: Q2 2026

Aug 6, 2026, 4:30 PM EDT - 12 days ago

Hyperfine Slides: Q2 2026

Aug 6, 2026, 4:05 PM EDT - 12 days ago

Hyperfine, Inc. Reports Second Quarter 2026 Financial Results

2026-07-30T12:39:17.000Z - 20 days ago

Hyperfine announces release of multiple peer-reviewed publications on Swoop

Jul 30, 2026, 8:15 AM EDT - 20 days ago

Hyperfine Announces the Release of Multiple Peer-Reviewed Publications, Expanding Clinical Evidence for the Swoop® System Across a Growing Number of Sites of Care

Jul 23, 2026, 4:05 PM EDT - 26 days ago

Hyperfine, Inc. to Announce Second Quarter 2026 Financial Results on August 6, 2026

2026-07-01T12:20:15.000Z - 7 weeks ago

Hyperfine announces European launch of next-generation Swoop system

Jul 1, 2026, 8:15 AM EDT - 7 weeks ago

Hyperfine Announces European Launch of Next-Generation Swoop® System

2026-06-22T12:33:01.000Z - 2 months ago

Hyperfine announces formation of Neurosurgery Advisory Council

Jun 22, 2026, 8:15 AM EDT - 2 months ago

Hyperfine Forms Global Neurosurgery Advisory Council to Support Expansion of Portable MRI in Neurosurgical Care

2026-06-18T12:29:10.000Z - 2 months ago

Hyperfine says Swoop system scan volume in the U.S. hits ‘record milestones’

Jun 18, 2026, 8:15 AM EDT - 2 months ago

Hyperfine Swoop® System Scan Volume in the United States Hits Record Milestones Across Multiple Sites of Care

Jun 4, 2026, 8:45 AM EDT - 2 months ago

Hyperfine Transcript: Jefferies Global Healthcare Conference 2026

2026-05-26T15:26:37.000Z - 3 months ago

Hyperfine to join Russell 2000, Russell 3000 Indexes

May 26, 2026, 8:15 AM EDT - 3 months ago

Hyperfine to Join Russell 2000® and Russell 3000® Indexes

2026-05-22T12:19:18.000Z - 3 months ago

Hyperfine presents PRIME study results on portable MRI at SAEM meeting

May 22, 2026, 8:15 AM EDT - 3 months ago

Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments

May 21, 2026, 10:00 AM EDT - 3 months ago

Hyperfine Transcript: AGM 2026

2026-05-15T17:16:21.000Z - 3 months ago

Hyperfine management to meet virtually with Lake Street

2026-05-15T17:09:38.000Z - 3 months ago

Hyperfine management to meet virtually with Oppenheimer

2026-05-13T14:09:00.000Z - 3 months ago

Hyperfine price target raised to $2 from $1.60 at B. Riley

2026-05-12T22:02:48.000Z - 3 months ago

Hyperfine reports Q1 EPS (9c), consensus (9c)

2026-05-12T22:00:18.000Z - 3 months ago

Hyperfine still sees FY26 revenue $20M-$22M, consensus $20.04M

2026-05-12T20:51:05.000Z - 3 months ago

Hyperfine files to sell 1.08M shares of Class A common stock for holders

May 12, 2026, 4:30 PM EDT - 3 months ago

Hyperfine Earnings Call Transcript: Q1 2026

May 12, 2026, 4:30 PM EDT - 3 months ago

Hyperfine Earnings release: Q1 2026

May 12, 2026, 4:30 PM EDT - 3 months ago

Hyperfine Quarterly report: Q1 2026

May 12, 2026, 4:30 PM EDT - 3 months ago

Hyperfine Slides: Q1 2026

May 12, 2026, 4:05 PM EDT - 3 months ago

Hyperfine, Inc. Reports First Quarter 2026 Financial Results

May 12, 2026, 8:00 AM EDT - 3 months ago

Hyperfine Registration statement: Registration filing

May 6, 2026, 4:05 PM EDT - 3 months ago

Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference

2026-04-29T14:46:17.000Z - 4 months ago

Hyperfine announces AIIMS New Delhi initiated clinical use of Swoop

Apr 29, 2026, 8:15 AM EDT - 4 months ago

Hyperfine Swoop® System Introduced as India's First Portable MRI for Bedside Brain Imaging at the Country's Leading Medical Institution

2026-04-29T11:33:03.000Z - 4 months ago

Hyperfine initiated with a Buy at BTIG

Apr 28, 2026, 4:05 PM EDT - 4 months ago

Hyperfine, Inc. to Announce First Quarter 2026 Financial Results on May 12, 2026

2026-04-09T14:24:32.000Z - 4 months ago

Hyperfine receives CE Marking, UK Conformity Assessment approval

Apr 9, 2026, 8:15 AM EDT - 4 months ago

Hyperfine Receives CE and UKCA Marks for Next-Generation Swoop® System and Latest Advancement in Optive AI™ Software

Apr 8, 2026, 8:00 AM EDT - 4 months ago

Hyperfine Proxy statement: Proxy filing

Apr 8, 2026, 8:00 AM EDT - 4 months ago

Hyperfine Proxy statement: Proxy filing

2026-03-23T12:10:42.000Z - 5 months ago

Horizon Technology provides $40M loan facility to Hyperfine

HRZN

Mar 23, 2026, 8:00 AM EDT - 5 months ago

Horizon Technology Finance Provides $40 Million Loan Facility to Hyperfine

HRZN

2026-03-19T12:56:16.000Z - 5 months ago

Hyperfine price target raised to $1.60 from $1.30 at B. Riley

Mar 18, 2026, 4:30 PM EDT - 5 months ago

Hyperfine Earnings Call Transcript: Q4 2025

Mar 18, 2026, 4:30 PM EDT - 5 months ago

Hyperfine Annual report: Q4 2025

Mar 18, 2026, 4:30 PM EDT - 5 months ago

Hyperfine Earnings release: Q4 2025

Mar 18, 2026, 4:30 PM EDT - 5 months ago

Hyperfine Slides: Q4 2025

Mar 18, 2026, 4:05 PM EDT - 5 months ago

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 5, 2026, 4:05 PM EST - 5 months ago

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026

Jan 27, 2026, 8:15 AM EST - 7 months ago

Hyperfine Announces Publication of Breakthrough Clinical Data Demonstrating the Swoop® System's Enhanced Stroke Detection Capabilities

Jan 20, 2026, 8:15 AM EST - 7 months ago

Hyperfine Announces NEURO PMR Study Results Showing High Diagnostic Value and Superior Patient Experience in Neurology Clinics

Jan 15, 2026, 8:15 AM EST - 7 months ago

Hyperfine Announces Enrollment of First Patient in Study to Expand Intended Use of the Swoop® System with Contrast Agents

Jan 12, 2026, 8:15 AM EST - 7 months ago

Hyperfine Reports Preliminary, Unaudited Fourth Quarter and Full Year 2025 Financial Results

Jan 12, 2026, 7:00 AM EST - 7 months ago

Hyperfine Slides: Investor presentation

Jan 6, 2026, 8:15 AM EST - 8 months ago

Hyperfine Announces First Peer-Reviewed Publication Demonstrating Significant Economic Benefits of Using the Swoop® AI-Powered Portable MRI System in Acute Hospital Care

Dec 17, 2025, 8:15 AM EST - 8 months ago

Hyperfine Announces Regulatory Approval of the Swoop® System in India

Dec 15, 2025, 8:15 AM EST - 8 months ago

Hyperfine Announces FDA Clearance of the First Optive AI™ Software Update with Advanced Diffusion Imaging Capability, Focused on Enhancing Stroke Detection with the Swoop® System

Dec 4, 2025, 8:10 AM EST - 9 months ago

Hyperfine Transcript: Piper Sandler 37th Annual Healthcare Conference

Dec 4, 2025, 7:00 AM EST - 9 months ago

Hyperfine Slides: Investor Presentation

Nov 20, 2025, 4:05 PM EST - 9 months ago

Hyperfine, Inc. to Participate in Upcoming Piper Sandler 37th Annual Healthcare Conference

Nov 19, 2025, 8:15 AM EST - 9 months ago

Hyperfine Awarded $3.7 Million Grant to Advance Global Brain Health

Nov 13, 2025, 4:30 PM EST - 9 months ago

Hyperfine Earnings Call Transcript: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

Hyperfine Quarterly report: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

Hyperfine Earnings release: Q3 2025

Nov 13, 2025, 4:30 PM EST - 9 months ago

Hyperfine Slides: Q3 2025

Nov 13, 2025, 4:05 PM EST - 9 months ago

Hyperfine, Inc. Reports Third Quarter 2025 Financial Results

Oct 30, 2025, 4:05 PM EDT - 10 months ago

Hyperfine, Inc. to Announce Third Quarter 2025 Financial Results on November 13, 2025

Oct 21, 2025, 8:15 AM EDT - 10 months ago

Hyperfine Announces First Patients Enrolled in PRISM PMR to Evaluate the Use of Next-Generation Swoop® System in the Operating Room Setting

Oct 16, 2025, 8:00 AM EDT - 10 months ago

Hyperfine Announces Pricing of $17.5 Million Public Offering

Oct 15, 2025, 4:06 PM EDT - 10 months ago

Hyperfine Announces Proposed Public Offering

Oct 15, 2025, 4:05 PM EDT - 10 months ago

Hyperfine Reports Preliminary, Unaudited Results for Third Quarter 2025, Signaling Strong Business Momentum Following the Launch of the Next Generation Swoop® System

Oct 13, 2025, 8:15 AM EDT - 11 months ago

Hyperfine Swoop® System Referenced in France's Largest Public Hospital Procurement Body to Facilitate Nationwide Purchases of Portable MRI Technology

Oct 6, 2025, 8:15 AM EDT - 11 months ago

Hyperfine Launches PULSE Platform to Accelerate Adoption and Innovation of AI-Powered Portable MRI

Sep 8, 2025, 12:00 PM EDT - 1 year ago

Hyperfine Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 2, 2025, 8:15 AM EDT - 1 year ago

Hyperfine Receives CE Mark and UKCA Approval for Optive AI™ Software, Expanding Global Commercialization of Latest AI-Powered Imaging Software

Aug 25, 2025, 8:15 AM EDT - 1 year ago

Hyperfine, Inc. to Participate in Upcoming Investor Conferences

Aug 13, 2025, 4:30 PM EDT - 1 year ago

Hyperfine Earnings Call Transcript: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 1 year ago

Hyperfine Quarterly report: Q2 2025

Aug 13, 2025, 4:30 PM EDT - 1 year ago

Hyperfine Earnings release: Q2 2025

Aug 13, 2025, 4:05 PM EDT - 1 year ago

Hyperfine, Inc. Reports Second Quarter 2025 Financial Results

Aug 13, 2025, 4:00 PM EDT - 1 year ago

Hyperfine Slides: Investor Presentation

Aug 4, 2025, 8:15 AM EDT - 1 year ago

Hyperfine Achieves Clinical Milestone Ahead of Plan With 100th Patient Enrolled in Neurology Office Study Using the Next-Generation Swoop® System

Jul 31, 2025, 8:15 AM EDT - 1 year ago

Hyperfine Announces First Patients Enrolled in PRIME Study Aimed at Accelerating Adoption of AI-Powered Portable MRI in Emergency Departments

Jul 30, 2025, 4:05 PM EDT - 1 year ago

Hyperfine, Inc. to Announce Second Quarter 2025 Financial Results on August 13, 2025

Jul 28, 2025, 8:15 AM EDT - 1 year ago

Hyperfine Swoop® AI-Powered Portable MRI System Demonstrates 100% Sensitivity for ARIA-E Detection in New Data Presented at the 2025 Alzheimer's Association International Conference

Jul 24, 2025, 8:15 AM EDT - 1 year ago

Hyperfine Swoop® AI-Powered Portable MRI System Showcased in Clinical Studies Designed to Broaden Access to Dementia Care

Jul 23, 2025, 8:15 AM EDT - 1 year ago

Hyperfine Begins Commercial Launch of Optive AI™ Software, Bringing Substantially Improved Image Quality to the Installed Base of Swoop® Systems

Jul 17, 2025, 8:15 AM EDT - 1 year ago

Hyperfine Announces the First Commercial Sales of the Next-Generation Swoop® System Powered by Optive AI™ Software

Jun 11, 2025, 9:00 AM EDT - 1 year ago

Hyperfine Announces Key Executive Appointments to Strengthen its Leadership Position in AI-Powered Portable MRI

Jun 5, 2025, 4:20 PM EDT - 1 year ago

Hyperfine Transcript: Jefferies Global Healthcare Conference 2025

Jun 2, 2025, 8:15 AM EDT - 1 year ago

Hyperfine Announces FDA Clearance of a New Next-Generation Swoop® System Powered by Optive AI™ Software, Delivering a Transformative Leap in Image Quality

May 28, 2025, 9:00 AM EDT - 1 year ago

Hyperfine Announces FDA Clearance of Optive AI™ Software, Introducing the Most Substantial Image Quality Improvement Ever for the Swoop® System

May 15, 2025, 4:05 PM EDT - 1 year ago

Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference

May 13, 2025, 4:30 PM EDT - 1 year ago

Hyperfine Earnings Call Transcript: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Hyperfine Quarterly report: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Hyperfine Earnings release: Q1 2025

May 13, 2025, 4:30 PM EDT - 1 year ago

Hyperfine Slides: Q1 2025

May 13, 2025, 4:05 PM EDT - 1 year ago

Hyperfine, Inc. Reports First Quarter 2025 Financial Results

Apr 29, 2025, 4:28 PM EDT - 1 year ago

Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025

Apr 15, 2025, 4:00 PM EDT - 1 year ago

Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices

Mickf2022 Aug. 12 at 9:42 PM

0 · Reply

Dynel Aug. 12 at 4:26 PM

$HYPR

0 · Reply

Cold_in_the_North Aug. 12 at 3:17 PM

$HYPR this would be a good place for insiders to make some buys, and show their confidence.

0 · Reply

Stockwhisperr Aug. 10 at 3:30 PM

2 · Reply

Number_4 Aug. 7 at 10:50 AM

$HYPR Always more of the same here. Mgmt CANNOT get sales traction, this name burns cash and now is fully using the ATM to dilute us longs!!!! Easier short ever if it gets back to $1.25.

0 · Reply

EarningsInsider Aug. 6 at 9:22 PM

https://www.marketbeat.com/earnings/reports/2026-8-6-hyperfine-inc-stock/ $HYPR Hyperfine Earnings Transcript

0 · Reply

Tl5000 Aug. 6 at 9:03 PM

$HYPR such a small market cap…cmon HYPR! Light at end of tunnel to get movin!!

0 · Reply

Cold_in_the_North Aug. 6 at 8:36 PM

$HYPR 4th consecutive quarter with gross profit margin over 50%

0 · Reply

StocktwitsEarnings Aug. 6 at 8:15 PM

$HYPR Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.09 up 25.00% YoY • Reported revenue of $3.9M up 44.81% YoY

0 · Reply

Cold_in_the_North Aug. 6 at 8:11 PM

$HYPR https://investors.hyperfine.io/news-releases/news-release-details/hyperfine-inc-reports-second-quarter-2026-financial-results/

0 · Reply

STACKD0E Aug. 6 at 4:58 PM

$HYPR $LDOS $VERI 🙃✨️

0 · Reply

Dynel Aug. 3 at 4:26 PM

$HYPR

0 · Reply

Zardiw Jul. 31 at 10:00 AM

#DDAmanda Pick Alerts for July 30, 2026: $BIOT, $VERI, $HYPR, $MVST, $NAUT https://DDAmanda.com

0 · Reply

Cold_in_the_North Jul. 30 at 1:32 PM

$HYPR https://investors.hyperfine.io/news-releases/news-release-details/hyperfine-announces-release-multiple-peer-reviewed-publications/

0 · Reply

STACKD0E Jul. 30 at 12:41 PM

$HYPR $LDOS $VERI ✨️

0 · Reply

BeeDecay Jul. 28 at 9:27 AM

$HYPD $HYPE.X $HYPR like clockwork.

1 · Reply

ModestlyMade Jul. 21 at 10:58 PM

$BFLY $QSI $HYPR and then he spends his days retweeting Zio Fascist trash all day. What a 🤡 Glad I sold 80% at 8.80. And the rest in the 7s.... Founder is a garbage humanbeing and would openly tell him to his weasel face.

1 · Reply

WhitespringMcGee Jul. 20 at 6:06 PM

$HYPR Went in hard today buying at discounted prices from a year ago.

0 · Reply

TheWideOpenRoad Jul. 20 at 12:35 PM

$HYPR $BFLY https://www.mpo-mag.com/breaking-news/india-begins-using-hyperfine-swoop-system-for-bedside-brain-imaging/

0 · Reply

TheWideOpenRoad Jul. 19 at 11:18 PM

$HYPR Rothberg sold 4M shares of BFLY. Maybe he will buy some HYPR with the proceeds…

0 · Reply

Cold_in_the_North Jul. 19 at 12:40 PM

$HYPR nearly doubled my position on Friday. This too shall pass

0 · Reply

Tl5000 Jul. 18 at 6:15 PM

$HYPR

0 · Reply

Market Cap	95.00M
Revenue (ttm)	13.56M
Net Income (ttm)	-35.57M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-262.32%
Debt to Equity Ratio	0.36

Volume	577,500
Avg Vol	1,102,812
Day's Range	N/A - N/A
Shares Out	106.05M
Stochastic %K	18%
Beta	1.43
Analysts	Strong Sell
Price Target	$2.03